Found 8 matching trials
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment
PHASE2In this study, the investigators provide a combined treatment of personaliz...
Location
First Affiliated Hospital of Nanchang University
Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer
PHASE1Various of immunotherapies are now widely applied in the treatment of lung ...
Location
Shenzhen People's Hospital
Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NAIn this study, the investigators provide a combined treatment of personaliz...
Location
First Affiliated Hospital of Nanchang University
Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
NAIn this study, the investigators provide a combined treatment of personaliz...
Location
First Affiliated Hospital of Nanchang University
Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery
PHASE1This is a single-center, single-arm phase I study to determine the safety a...
Location
Beijing Tiantan Hospital
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
NAIn this study, the investigators provide a combined treatment of personaliz...
Location
First Affiliated Hospital of Nanchang University
YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer
PHASE1This phase I study tests a personalized cancer vaccine (Neo-DC) for men wit...
Status
Enrolling By Invitation
Location
Shanghai Changhai Hospital
DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs
EARLY_PHASE1This is a single-center, single-arm, prospective clinical trial to investig...
Location
West China Hospital